Series B · JPY 600M · November 2026 · Medical devices & diagnostics · Japan
Quadlytics develops an epileptic seizure prediction algorithm based on heart-rate-variability analysis, aiming to deliver an app as a medical device.
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-11-04 | Series B | JPY 600M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-11-10.
EnVision Endoscopy makes the SimpleStitch Suturing System, a single-use device that mounts on a standard flexible endoscope to place sutures and approximate soft tissue, for…
Builds miniature radar seekers that turn cheap drones into precision interceptors, holding a lock through darkness, smoke and weather. Main product is the Heimdall guided…
Spatiotemporal multimodal data platform for robotics companies, covering data collection, monitoring, diagnosis, testing and management across R&D, test, production and operations.
Ultrasonic phaco-vitrectomy medical devices
Laza Medical develops intelligent imaging with robotic ultrasound probe control for cardiac procedures (structural heart and electrophysiology), so clinicians can image with more…
Makes Brijjit, a force-modulating tissue bridge that relieves tension around surgical incisions.
